Montana § 33-22-171 Maximum Allowable Cost List -- Limitations On Drugs

Montana Statutes

§ 33-22-171 — Maximum Allowable Cost List -- Limitations On Drugs

Montana § 33-22-171

Title 33INSURANCE AND INSURANCE COMPANIES

Ch. 22DISABILITY INSURANCE

Part 1General Provisions

This text of Montana § 33-22-171 (Maximum Allowable Cost List -- Limitations On Drugs) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 33-22-171 (2026).

Text

33-22-171 . (Temporary) Maximum allowable cost list -- limitations on drugs. Before a pharmacy benefit manager places or continues a drug on a maximum allowable cost list, the drug:

(1)must be listed as "A" or "B" rated in the most recent version of the United States food and drug administration's approved drug products with therapeutic equivalence evaluations or have an "NR" or "NA" rating by a nationally recognized reference;

(2)must be available for purchase by pharmacies in this state from national or regional wholesalers; and

(3)may not be obsolete, temporarily unavailable, or listed on a drug shortage list. (Terminates June 30, 2029--sec. 8, Ch. 474, L. 2025.)

Free access — add to your briefcase to read the full text and ask questions with AI

33-22-171 . (Temporary) Maximum allowable cost list -- limitations on drugs. Before a pharmacy benefit manager places or continues a drug on a maximum allowable cost list, the drug:
(1) must be listed as "A" or "B" rated in the most recent version of the United States food and drug administration's approved drug products with therapeutic equivalence evaluations or have an "NR" or "NA" rating by a nationally recognized reference;
(2) must be available for purchase by pharmacies in this state from national or regional wholesalers; and
(3) may not be obsolete, temporarily unavailable, or listed on a drug shortage list. (Terminates June 30, 2029--sec. 8, Ch. 474, L. 2025.)